Stockhub

Jiangsu Hengrui Medicine Co., Ltd.: Revision history

View logs for this page

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

27 September 2022

  • curprev 09:3509:35, 27 September 2022‎ 95.149.241.133 talk‎ 598 bytes +598‎ Created page with "== Summary<ref>Source: Yahoo Finance.</ref> == Jiangsu Hengrui Medicine Co., Ltd., a pharmaceutical company, researches, develops, manufactures, and commercializes medicine worldwide. The company is developing Apatinib, Pyrotinib, Mecapegfilgrastim, SHR3680, SHR3162, SHR9549, SHR2554, SHR1459, SHR-1309, SHR-A1201, Camrelizumab, Famitinib, SHR-1316, SHR-1501, SHR-1603, SHR-1701, SHR-1702, and SHR-A1403 for oncology, metabolic, pain, autoimmune, and other indications. The..." Tag: Visual edit: Switched
Retrieved from ‘https://stockhub.co/research/Jiangsu_Hengrui_Medicine_Co.,_Ltd.’